Advertisement US Patent Office allows second Vnus patent application - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

US Patent Office allows second Vnus patent application

Vnus Medical Technologies has announced that the US Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the Vnus patent infringement lawsuit against suppliers of endovenous laser products.

This comes on the heels of the Patent Office’s decision in April, 2008 to allow Vnus a separate patent application, also filed as a continuation of one of the patents in the lawsuit. Vnus has sued several endovenous laser manufacturers (Diomed, Angiodynamics, and Vascular Solutions) for infringement of Vnus patents. That lawsuit is currently scheduled to begin trial against non-bankrupt defendants Angiodynamics and Vascular Solutions on June 23, 2008.

The newly allowed Vnus patent application contains claims that recite methods of administering fluid around a hollow anatomical structure, such as a vein in a lower limb, and applying energy from an elongate member to the hollow anatomical structure.

Brian Farley, Vnus president and CEO, said: “The newly allowed claims provide additional, meaningful breadth to our patent position and will be a significant asset for protecting our endovenous ablation technology.”